Advanced Filters
noise

myocardial-ischemia Clinical Trials

A listing of myocardial-ischemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 796 clinical trials
C Chien-Boon Jong, MD

A Study of Pressure Waveform Analysis in Coronary Artery-II

The goal of this observational study is to test the feasibility of intracoronary adenosine administration during coronary flow reserve(CFR) and index of microcirculatory resistance(IMR) assessment in a population with angina. The main questions it aims to answer are Repeatability of CFR and IMR assessment while hyperemia with intracoronary adenosine was …

21 years of age All Phase N/A
H Héctor Rodríguez, Dr. med.

Depressive Symptoms After Cardiac Surgery

The primary goal of this project is to develop a predictive model for clinically significant depressive symptoms (CSDS) in patients undergoing coronary artery bypass graft (CABG) surgery, using pre- and perioperative data. CSDS occur in about 30 percent of CABG patients, which is four times higher than in the general …

18 - 90 years of age All Phase N/A
K Ki Hong Choi, MD

Distribution and Clinical Implication of CMD in Patients With HFpEF Without Significant CAD

To evaluate the incidence of coronary microvascular dysfunction (CMD) and its' prognostic implication in patients who have diagnosed as heart failure with preserved ejection fraction (HFpEF) confirmed by HFA-PEFF scoring system without functionally significant coronary artery disease.

19 years of age All Phase N/A
B Babak Khanderoo

Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery

Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients treated with minimally invasive approach, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery rates, and the role of standard work to improve patient outcomes and reduce surgical …

18 years of age All Phase N/A

Milrinone on Right Ventricular Strain in Cardiac Surgery

The purpose of this study is to analyze the changes in right ventricular strain before and after milrinone administration in order to find out whether milrinone improves RV systolic performance in patients undergoing cardiac surgery.

20 years of age All Phase N/A

Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice

This study evaluates the effectiveness and safety rotational atherectomy in routine clinical practice.

19 years of age All Phase N/A
C Camilla Torlasco, M.D.

CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF

Heart failure with preserved ejection fraction (HFpEF) causes hospitalizations, premature mortality and high health care costs. This is also due to poor understanding of HFpEF pathogenesis and, thus, lack of specific therapies. Prompted by the recent demonstration that HFpEF clusters different clinical phenotypes, the investigators propose that these phenogroups are …

18 years of age All Phase N/A
M Marilia Gomes

A 36-month Analysis of the Clinical Performance of Individualized CAD/CAM-produced Dental Implants: a Cohort Study

The goal of this prospective cohort study is to evaluate the clinical performance of a new generation of customized CAD/CAM pre-fabricated root-analog dental implants over a 36-month period. The main questions it aims to answer are: Are these novel implants safe, effective, and clinically viable for 36 months? Do these …

years of age All Phase N/A
K Katie Cornella, PA

AngelMed Guardian® System PMA Post Approval Study

500 Patients (minimum) will be enrolled following commercial implant. Will be treated by their physicians using the standard of care. Standard of care for the Guardian includes an in-office initial programming visit 7-14 days following implant and every 6 months.

21 years of age All Phase N/A
J Joseph Cheriyan, MBChB, FRCP

Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study

The preceding IVORY trial (NCT04241601) has completed. As atherosclerosis and its complications are driven by inflammation the investigators hypothesise that treatment with low-dose IL2 may reduce adverse cardiovascular outcomes compared to placebo. In this follow-up study, the investigators aim to collect cardiovascular clinical outcome data for patients who completed the …

18 - 85 years of age All Phase N/A

Simplify language using AI